Jason Gardner, Flagship CEO-Partner and CEO of Ampersand Biomedicines, explains how Ampersand’s platform is creating biologics that can go exactly where they are needed in the body to drive increased benefits for patients. For more on developments in Ampersand’s platform and its recent partnership with Pfizer. More from Flagship @ JPM2025 here.
Related Companies
- Ampersand Biomedicines Founded: 2021
